Show Summary Details
Page of

Toxidromes: Toxicology and the Psychiatric Patient 

Toxidromes: Toxicology and the Psychiatric Patient
Chapter:
Toxidromes: Toxicology and the Psychiatric Patient
Author(s):

Michael G. Abesamis

DOI:
10.1093/med/9780199329311.003.0015
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 October 2020

Psychiatric patients are unique among patients who present with drug toxicity due to the wide variety of substances that they may have access to. Not only do these medications affect numerous neurologic receptors, they also have significant potential for drug interactions that can lead to morbidity and mortality. Regardless of the toxin causing the presenting ailment, identifying the clinical pattern or toxidrome is the key to guiding therapy for these individuals. This chapter reviews the basic presentations of the anticholinergic, cholinergic, sympathomimetic, and sedative-hypnotic toxidromes. Morever, it lists some of the common drugs associated with each pattern. Finally, it presents an evidence-based approach to each treatment. The tricyclic antidepressant and monoamine oxidase inhibitor toxicities are also specifically highlighted.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.